Bristol John W & Co. Inc. NY lessened its stake in shares of Monsanto (NYSE:MON) by 4.8% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 211,085 shares of the basic materials company’s stock after selling 10,578 shares during the period. Bristol John W & Co. Inc. NY’s holdings in Monsanto were worth $24,651,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. lifted its position in shares of Monsanto by 2.6% during the 2nd quarter. Vanguard Group Inc. now owns 30,725,725 shares of the basic materials company’s stock worth $3,636,697,000 after buying an additional 784,418 shares during the period. BlackRock Inc. lifted its position in shares of Monsanto by 6.5% during the 2nd quarter. BlackRock Inc. now owns 27,898,255 shares of the basic materials company’s stock worth $3,302,038,000 after buying an additional 1,705,439 shares during the period. State Street Corp raised its position in Monsanto by 0.6% in the 2nd quarter. State Street Corp now owns 20,276,780 shares of the basic materials company’s stock valued at $2,399,965,000 after purchasing an additional 122,814 shares during the last quarter. Capital International Investors raised its position in Monsanto by 10.3% in the 3rd quarter. Capital International Investors now owns 9,344,430 shares of the basic materials company’s stock valued at $1,119,650,000 after purchasing an additional 872,377 shares during the last quarter. Finally, Northern Trust Corp raised its position in Monsanto by 0.7% in the 2nd quarter. Northern Trust Corp now owns 7,092,929 shares of the basic materials company’s stock valued at $839,519,000 after purchasing an additional 47,725 shares during the last quarter. Institutional investors and hedge funds own 75.34% of the company’s stock.

Several equities analysts have issued reports on MON shares. BMO Capital Markets reiterated a “buy” rating and issued a $128.00 price objective on shares of Monsanto in a research report on Thursday, October 5th. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $132.00 price objective for the company in a research report on Thursday, September 14th. Barclays reiterated an “equal weight” rating and issued a $124.00 price objective (up previously from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. Jefferies Group reiterated a “hold” rating and issued a $128.00 price objective on shares of Monsanto in a research report on Friday, September 15th. Finally, Royal Bank of Canada reiterated a “hold” rating and issued a $128.00 price objective on shares of Monsanto in a research report on Wednesday, November 15th. Eleven analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $126.40.

In other news, CFO Pierre Courduroux sold 4,320 shares of Monsanto stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $122.00, for a total value of $527,040.00. Following the completion of the sale, the chief financial officer now directly owns 48,388 shares of the company’s stock, valued at approximately $5,903,336. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Nicole M. Ringenberg sold 7,890 shares of Monsanto stock in a transaction on Monday, October 16th. The shares were sold at an average price of $122.25, for a total value of $964,552.50. Following the completion of the sale, the vice president now directly owns 38,600 shares of the company’s stock, valued at $4,718,850. The disclosure for this sale can be found here. 0.70% of the stock is currently owned by company insiders.

Monsanto (NYSE:MON) opened at $118.83 on Thursday. The stock has a market capitalization of $52,310.00, a price-to-earnings ratio of 21.96, a price-to-earnings-growth ratio of 1.69 and a beta of 1.04. Monsanto has a 52-week low of $106.74 and a 52-week high of $122.79. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.28 and a quick ratio of 0.79.

Monsanto (NYSE:MON) last released its earnings results on Thursday, January 4th. The basic materials company reported $0.41 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.42 by ($0.01). The firm had revenue of $2.66 billion during the quarter, compared to analyst estimates of $2.77 billion. Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The firm’s quarterly revenue was up .3% on a year-over-year basis. During the same period last year, the business posted $0.21 earnings per share. equities research analysts expect that Monsanto will post 5.79 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, January 5th will be paid a $0.54 dividend. The ex-dividend date is Thursday, January 4th. This represents a $2.16 annualized dividend and a dividend yield of 1.82%. Monsanto’s dividend payout ratio (DPR) is currently 39.93%.

COPYRIGHT VIOLATION WARNING: “Bristol John W & Co. Inc. NY Has $24.65 Million Position in Monsanto (MON)” was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.watchlistnews.com/bristol-john-w-co-inc-ny-has-24-65-million-position-in-monsanto-mon/1802667.html.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.